{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:11:55Z","timestamp":1789668715715,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20031-6","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:22:12Z","timestamp":1783603332000},"page":"9496-9504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of Neoadjuvant Radiotherapy Followed by Robotic Radical Prostatectomy in High-Risk Locally Advanced Prostate Cancer: A Prospective Pilot Study"],"prefix":"10.1245","volume":"33","author":[{"given":"Chi-Shin","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Kai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-Ju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Chia-Hsien","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"7","key":"20031_CR1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1200\/JCO.2009.26.0133","volume":"28","author":"MR Cooperberg","year":"2010","unstructured":"Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28(7):1117\u201323.","journal-title":"J Clin Oncol"},{"issue":"11","key":"20031_CR2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D'Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969\u201374.","journal-title":"JAMA"},{"issue":"1","key":"20031_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.juro.2006.08.057","volume":"177","author":"CJ Kane","year":"2007","unstructured":"Kane CJ, Presti JC Jr, Amling CL, et al. Search database study group changing nature of high risk patients undergoing radical prostatectomy. J Urol. 2007;177(1):113\u20137.","journal-title":"J Urol"},{"issue":"9","key":"20031_CR4","doi-asserted-by":"publisher","first-page":"e2332900","DOI":"10.1001\/jamanetworkopen.2023.32900","volume":"6","author":"UG Falagario","year":"2023","unstructured":"Falagario UG, Abbadi A, Remmers S, et al. Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy. JAMA Netw Open. 2023;6(9):e2332900.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"20031_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12885-023-10842-1","volume":"23","author":"BL Heesterman","year":"2023","unstructured":"Heesterman BL, Aben KKH, de Jong IJ, et al. Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review. BMC Cancer. 2023;23(1):398.","journal-title":"BMC Cancer"},{"issue":"2","key":"20031_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jamaoncol.2018.4836","volume":"5","author":"D Tilki","year":"2019","unstructured":"Tilki D, Chen MH, Wu JH, et al. Surgery vs radiotherapy in the management of biopsy gleason score 9\u201310 prostate cancer and the risk of mortality. JAMA Oncol. 2019;5(2):213\u201320.","journal-title":"JAMA Oncol"},{"issue":"3","key":"20031_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41391-017-0009-6","volume":"21","author":"RR McKay","year":"2018","unstructured":"McKay RR, Montgomery B, Xie W, et al. Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade. Prostate Cancer Prostatic Dis. 2018;21(3):364\u201372.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"20031_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijrobp.2022.07.016","volume":"115","author":"L Hammer","year":"2023","unstructured":"Hammer L, Jiang R, Hearn J, et al. A phase I trial of neoadjuvant stereotactic body radiotherapy prior to radical prostatectomy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys. 2023;115(1):132\u201341.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"20031_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ijrobp.2020.06.010","volume":"108","author":"NR Parikh","year":"2020","unstructured":"Parikh NR, Kishan AU, Kane N, et al. Phase 1 trial of stereotactic body radiation therapy neoadjuvant to radical prostatectomy for patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2020;108(4):930\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"20031_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijrobp.2018.12.054","volume":"104","author":"R Glicksman","year":"2019","unstructured":"Glicksman R, Sanmamed N, Thoms J, et al. A phase 1 pilot study of preoperative radiation therapy for prostate cancer: long-term toxicity and oncologic outcomes. Int J Radiat Oncol Biol Phys. 2019;104(1):61\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"20031_CR11","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, et al. Group german rectal cancer study. preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731\u201340.","journal-title":"N Engl J Med"},{"issue":"22","key":"20031_CR12","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, et al. Cross group preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074\u201384.","journal-title":"N Engl J Med"},{"issue":"3","key":"20031_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019;76(3):340\u201351.","journal-title":"Eur Urol"},{"issue":"9","key":"20031_CR14","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1007\/s11605-012-1936-0","volume":"16","author":"PJ Nisar","year":"2012","unstructured":"Nisar PJ, Lavery IC, Kiran RP. Influence of neoadjuvant radiotherapy on anastomotic leak after restorative resection for rectal cancer. J Gastrointest Surg. 2012;16(9):1750\u20137.","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"20031_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1159\/000020366","volume":"38","author":"CC Schulman","year":"2000","unstructured":"Schulman CC, Debruyne FM, Forster G, et al. 4-year follow-up results of a european prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2\u20133n0m0 prostate cancer. european study group on neoadjuvant treatment of prostate cancer. Eur Urol. 2000;38(6):706\u201313.","journal-title":"Eur Urol"},{"issue":"1","key":"20031_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0022-5347(05)65393-1","volume":"167","author":"MS Soloway","year":"2002","unstructured":"Soloway MS, Pareek K, Sharifi R, et al. Group lupron depot neoadjuvant prostate cancer study. neoadjuvant androgen ablation before radical prostatectomy in Ct2bnxmo prostate cancer: 5-year results. J Urol. 2002;167(1):112\u20136.","journal-title":"J Urol"},{"issue":"4","key":"20031_CR17","doi-asserted-by":"publisher","first-page":"e607","DOI":"10.1016\/j.crad.2023.12.022","volume":"79","author":"FB Franco","year":"2024","unstructured":"Franco FB, Leeman JE, Fedorov A, et al. Early change in apparent diffusion coefficient as a predictor of response to neoadjuvant androgen deprivation and external beam radiation therapy for intermediate-to high-risk prostate cancer. Clin Radiol. 2024;79(4):e607\u201315.","journal-title":"Clin Radiol"},{"issue":"9","key":"20031_CR18","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1158\/1078-0432.CCR-16-1357","volume":"23","author":"B Montgomery","year":"2017","unstructured":"Montgomery B, Tretiakova MS, Joshua AM, et al. Neoadjuvant enzalutamide prior to prostatectomy. Clin Cancer Res. 2017;23(9):2169\u201376.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"20031_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1200\/JCO.2012.48.6431","volume":"32","author":"EA Mostaghel","year":"2014","unstructured":"Mostaghel EA, Nelson PS, Lange P, et al. Targeted androgen pathway suppression in localized prostate cancer: a pilot study. J Clin Oncol. 2014;32(3):229\u201337.","journal-title":"J Clin Oncol"},{"issue":"33","key":"20031_CR20","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1200\/JCO.2013.53.4578","volume":"32","author":"ME Taplin","year":"2014","unstructured":"Taplin ME, Montgomery B, Logothetis CJ, et al. Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study. J Clin Oncol. 2014;32(33):3705\u201315.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20031-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:53:25Z","timestamp":1789667605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20031-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20031"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20031-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have nothing to disclose.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the institutional review board of National Taiwan University Hospital (IRB No: 202101088RINA). The trial was registered at ClinicalTrials.gov (NCT04894188). Written informed consent was obtained from all participants prior to inclusion in the study. The trial was conducted in accordance with the ethical standards of the institutional research committee and the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}